Mediso Medical Imaging Systems Ltd.
Mediso is active in nuclear medicine since 1990 with a profile of development, manufacturing, selling and servicing molecular imaging multi-modality devices. It offers complete solutions from hardware design to evaluation and quantification software for clinical patient care and scientific research.
With 30-year expertise, 1,300+ clinical cameras, Mediso is within the leaders in clinical patient care. Besides a unique triple modality clinical SPECT-CT-PET hybrid system, Mediso launched the new AnyScan® TRIO family which has a triple head SPECT detector design and dedicated multi-pinhole collimation technology.
Mediso has a leader position in the preclinical nuclear imaging market with 250+ commissioned preclinical cameras around the world. Beyond the market leading nanoScan® PET/CT and SPECT/CT, Mediso launched the world's first integrated PET/MRI and SPECT/MRI systems. Products are sold directly or through a network of distributors in 100+ countries worldwide.